Alternate-Day, Low-Dose Aspirin and Cancer Risk
Menée sur une cohorte de 33 682 participantes âgées de 45 ans ou plus et en bonne santé, cet essai randomisé évalue l'association entre l'utilisation, alternée et à long terme, d'une faible dose d'aspirine et le risque de cancer (5 071 cas)
In this issue, Cook and colleagues examined treatment with alternate-day, low-dose aspirin in middle-aged women in the Women's Health Study. The editorialist discusses the study's findings and concludes that they should temper any recommendations for widespread use of aspirin in healthy middle-aged women and reinforce the need to consider the risks and benefits of aspirin separately in men and women...
Annals of Internal Medicine , éditorial, 2012